Related Experiment Video

Updated: Jun 8, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Science of weight loss supplements: compromised by conflicts of interest?

Ano Lobb

    World Journal of Gastroenterology
    |October 13, 2010
    PubMed

    Insights

    Weight loss supplements may pose risks due to potent ingredients and flawed research. Improved conflict of interest disclosures and regulatory oversight are crucial for consumer safety.

    Area of Science:

    • Pharmacology
    • Nutritional Science
    • Regulatory Science

    Background:

    • Weight loss supplements frequently contain potent pharmacoactive ingredients with potential health risks.
    • Clinical trials for these supplements are often small, short-term, and may lack transparency regarding financial conflicts of interest.

    Discussion:

    • The combination of ingredient risks and inadequate research raises consumer safety concerns.
    • Published research, particularly for weight loss products, may be used in marketing to imply scientific validation, potentially misleading consumers.
    • Specific products like Metabolife-356, Hydroxycut, Xenadrine, and LeptiCore have been associated with research quality issues or conflicts of interest.

    Key Insights:

    • Flawed research and undisclosed conflicts of interest in weight loss supplement studies can endanger consumers.
    • Marketing claims may overstate the safety and effectiveness of these products based on compromised scientific evidence.

    Outlook:

    • Enhanced conflict of interest disclosure in published research is essential.
    • Regulatory bodies should re-evaluate how research findings are integrated into marketing claims for weight loss supplements to ensure accuracy and protect public health.

    More Related Videos

    Control of Eating Behavior Using a Novel Feedback System04:48

    Control of Eating Behavior Using a Novel Feedback System

    Published on: May 8, 2018

    Related Concept Videos

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

    Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
    Confirmation Biases01:31

    Confirmation Biases

    The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias?
    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

    Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
    Blind Procedures02:07

    Blind Procedures

    Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...